ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $230,000 | +360.0% | 12,198 | +183.1% | 0.00% | – |
| Q2 2019 | $50,000 | -86.7% | 4,309 | -84.4% | 0.00% | -100.0% |
| Q1 2019 | $377,000 | +9325.0% | 27,663 | +5913.7% | 0.00% | – |
| Q4 2018 | $4,000 | -97.1% | 460 | -94.5% | 0.00% | – |
| Q3 2018 | $140,000 | -29.6% | 8,409 | -33.3% | 0.00% | -100.0% |
| Q2 2018 | $199,000 | +114.0% | 12,614 | +55.2% | 0.00% | -75.0% |
| Q4 2017 | $93,000 | +63.2% | 8,126 | +74.3% | 0.00% | +100.0% |
| Q3 2017 | $57,000 | -83.6% | 4,661 | -84.7% | 0.00% | -86.7% |
| Q2 2017 | $347,000 | +1234.6% | 30,369 | +2298.8% | 0.02% | +1400.0% |
| Q1 2017 | $26,000 | – | 1,266 | +4265.5% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 29 | -90.2% | 0.00% | – |
| Q2 2016 | $7,000 | -97.9% | 296 | -97.8% | 0.00% | -100.0% |
| Q1 2016 | $332,000 | +219.2% | 13,564 | +329.2% | 0.03% | +225.0% |
| Q4 2015 | $104,000 | -86.4% | 3,160 | -86.5% | 0.01% | -85.7% |
| Q3 2015 | $764,000 | +594.5% | 23,346 | +1023.5% | 0.06% | +522.2% |
| Q2 2015 | $110,000 | – | 2,078 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |